Hinge Health IPO: Perfect Alignment or Needs more Rehab?
This page contains links to our partners. We may be compensated when a link is clicked. Read the disclosures to learn more.
Explore opportunities to invest in the Hinge Health IPO as the IPO date approaches — now delayed due to tariffs. The S-1 IPO filing went live on March 10th. Hinge Health will trade on the NYSE under the stock symbol “HNGE”.
However, tariff turmoil has caused IPO delays across the board.
Invest in pre-IPO startups like OpenAI, Anthropic, and Canva via the Fundrise Innovation Fund.
Table of Contents
Notable Hinge Health News
04/04/2025: Hinge Health is considering delaying its IPO
04/04/2025: Tariff Turmoil Freezes the U.S. IPO Market
03/10/2025: Hinge Health S-1 Live
03/07/2025: Hinge Health Weighs IPO Filing as Soon as Next Week
Older news…
About Hinge Health
Hinge Health is a digital clinic that provides online-delivered physical therapy for muscle and joint pain.
The company was founded in 2014 by Daniel Perez and Gabriel Mecklenburg after both experiencing traumatic injuries requiring musculoskeletal (MSK) rehabilitation.
Its products and services revolve around digital physical therapy and MSK care solutions, using wearable sensors, AI-driven coaching, and virtual physical therapists to help patients manage chronic pain, recover from injuries, and reduce the need for opioid-based pain relief.
The personalized exercise therapy programs and one-on-one coaching for back and joint pain are provided through an app-based platform for employers and health plans, addressing shortages and high costs of in-person physical therapy appointments.
Headquartered in San Francisco, California, Hinge Health has become a leader in the digital MSK health space, serving millions of members across the U.S.
It faces competition from other digital health startups like Sword Health, Kaia Health, and traditional physical therapy facilities.
Here is a recent podcast episode on the upcoming Hinge Health IPO:
IPO Terms
- IPO Date: DELAYED
- Stock Symbol: “HNGE”
- Exchange: NYSE
- Common Stock Offered: TBD
- IPO Valuation: TBD
- Raise: TBD
- Lead Underwriters: Morgan Stanley, Barclays, B of A
- IPO Roadshow: TBD
- IPO Price: TBD
- Opening Trade: TBD
- Opening Trade Time: TBD
Hinge Health S-1 Filing
Here is the March 10th version of the Hinge Health S-1 filing:
Get the Hinge Health S-1 filing here.
Ownership
Hinge Health is a venture-backed private company. Equity stakeholders include the founders, employees, and venture capital firms.
The latest funding round raised $400 million in October 2021. The company has raised more than $800 million in private funding since its founding in 2014.
Prominent venture capital investors include Coatue, Tiger Global, Bessemer, Atomico, Leading Edge Capital, Insight Partners, Quadrille Capital, IP Group, Alkeon, Whale Rock, and Heuristic Capital.
Funding Rounds
| Round | Date | Est. Valuation | Raise Amount | Price |
|---|---|---|---|---|
| Series E | 10/27/21 | $6.20B | $400.00M | $ 77.46 |
| Series D | 01/05/21 | $3.00B | $300.00M | $ 43.72 |
| Series C | 02/03/20 | $435.90M | $90.00M | $ 7.31 |
| Series B | 08/08/18 | $90.00M | $26.00M | $ 2.26 |
| Series A | 07/23/17 | $26.40M | $9.57M | $ 1.03 |
| Source: Caplight |
Valuation
The latest confirmed Hinge Health valuation is $6.2 billion based on the October 2021 Series E funding round. However, late 2021 marked peak euphoria in the private fundraising markets.
The valuation as of March 2025 is likely below that value. Private marketplace data from various sources suggest the valuation is less than $3 billion.
The amended IPO filing will provide details on the size of the offering and estimated market cap.
Monitor the pre-IPO marketplaces for private share availability headed into the IPO.
IPO Potential
The specific Hinge Health IPO date is currently unknown. However, the company released its S-1 IPO filing to the public on March 10th, 2025, suggesting an April 2025 IPO.
Barring any substantial red flags in the S-1, the IPO should happen in the next four to five weeks.
Morgan Stanley is the lead bookrunner.
How to Invest in Hinge Health Stock
Retail investors can monitor pre-IPO marketplace platforms for opportunities to invest in Hinge Health today,
However, with a reported IPO in the works, opportunities are likely to be limited.
Accredited investors may find direct investment opportunities as more shares become available on pre-IPO investing platforms.
1. Participate in the Hinge Health IPO
IPO investors may find opportunities to invest during the IPO when it arrives — acquiring shares at the IPO price the day before the stock begins trading on the open market.
Once reserved for Wall Street’s wealthiest customers, IPO access has become more attainable to retail investors in the past few years.
The following online brokers give customers free access to IPOs, even with low account balances:
TradeStation has a longer track record of accessing more than 400 IPOs and secondary offerings via its partnership with Click Markets.
But Robinhood has the advantage of Silicon Valley networks and a history of getting more allocations in recent years.
With Morgan Stanley as lead bookrunning and a less than $5 billion IPO, shares may be hard to come by.
Check out this list of best brokers for IPO investing to learn more about IPO access for retail investors.
2. Monitor pre-IPO Marketplaces for Share Availability
Platforms such as Linqto, Hiive, EquityZen, and Forge Global may still offer secondary investment access.
However, as we approach the IPO date, current investors are less likely to sell shares into the IPO.
These platforms allow employees and early shareholders to liquidate shares with limited liquidity elsewhere. Accredited retail investors can sometimes invest, often at lowered valuations.
Investment minimums range from $1,000 to $50,000 or more on these platforms. Platform availability of a company of this size (under $5 billion valuation) may be limited.
Investors can sign up for free access to pre-IPO data and alerts and monitor startup share availability.
Another way to invest in pre-IPO companies is via the Fundrise Innovation Fund. Ordinary investors can own startups like Databricks, Canva, Anthropic, Anduril, and others through the Fund.
Hinge Health is not part of the portfolio at this time.
Check out our list of top pre-IPO investing platforms for current share availability across platforms.
Please note: This is a testimonial in partnership with Fundrise. We earn a commission from partner links on AccessIPOs.com. All opinions are my own.
3. Directed Share Program
The S-1 filing has no indications of a directed share program for retail investors.
4. Buy the stock after the IPO
Even for seasoned investors like many of our readers, accessing private shares or securing an allocation during the IPO is somewhat challenging.
However, waiting to invest can be worthwhile. IPO filings open more financial insights, adding more depth to the public company’s operations each quarter.
IPOs can sometimes give us quick gains, especially for companies in high demand. Timing is critical — being an early investor can lead to lucrative gains when strategically selling during a peak.
For those without IPO access, the post-IPO temptation to grab shares at inflated prices is real. Resist the urge to chase overpriced shares when shares begin trading.
History shows that stock prices often dip after the initial enthusiasm (eventually, below the IPO price), creating attractive price entry points for long-term investors.
Selectivity and patience can distinguish between gains and dead money. The most groundbreaking companies tend to command higher valuations a decade down the line.
So, resist the urge to follow the crowd and focus on the long game for potential lasting wealth.
Frequently Asked Questions (FAQs)
Is Hinge Health Stock Publicly Traded?
Not yet. Hinge Health is not publicly traded yet. We expect the stock to begin trading in April 2025.
What is the Hinge Health Stock Symbol?
The Hinge Health stock symbol will be “HNGE”.
What is the Hinge Health Stock Price?
A public Hinge Health stock price does not exist because the company is private.
The October 2021 Series E funding round was completed at $77.46 per share. That price point is out of date.
More recent pre-IPO marketplace data suggests the stock price is closer to $30 per share as of March 2025.
Hinge Health News Archive
09/26/2024: Hinge Health Hires Morgan Stanley to Lead IPO
10/28/2021: Hinge Health Announces $600 Million Investment
01/08/2021: Hinge Health raises $300M Series D
02/04/2020: Hinge Health closes $90M Series C
08/09/2018: Hinge Health Raises $26 Million
07/24/2017: Hinge Health raises $8M Series A
Conclusion
Hinge Health’s growth and popularity highlight the trending transformation of digital healthcare, which is especially accessible in musculoskeletal care.
As a pioneer in the space, the company has successfully combined AI, virtual therapy, and wearable technology to address a critical gap in traditional physical therapy.
However, its future as a public company will depend on how well it navigates market conditions and investor expectations amid shifting valuations.
IPO volume remains thin, though a Hinge Health IPO could ignite further enthusiasm for health companies to consider public offerings.
The potential IPO presents both risks and opportunities. Early investors may seek liquidity, while new investors will weigh the company’s long-term growth prospects.
Patience and due diligence will be key for those considering an entry point. Whether Hinge Health thrives post-IPO will hinge on its ability to scale profitably, differentiate itself from competitors, and sustain employer and insurer adoption.
For those monitoring the space, the coming months could provide critical insights into whether this digital health leader will continue to redefine the industry or face growing pressures in an evolving market.
Monitor this page for the latest news and insights for the Hinge Health IPO.
Craig Stephens is a former IT professional who left his 19-year consulting career at the IRS to be a full-time finance writer. He started Access IPOs in 2016 to provide a resource for ordinary investors pursuing investment access to IPOs and pre-IPO startups. Craig studied Finance at Michigan State University and lives in Northern Virginia with his wife and three children. Learn more about Craig.
* This is a testimonial in partnership with Fundrise, Hiive, and other affiliate partners. We earn a commission from partner links on AccessIPOs.com. All opinions are my own. If you sign up with one of our partners through certain on this website, Access IPOs will be compensated at no additional cost to the reader. See the full disclosure here. Risk Statement: Investing in IPOs and pre-IPO startups involves significant risk. Do not invest in companies based solely on what is included in this article. Only invest in IPOs and pre-IPO companies with money you can afford to lose. Access IPOs is for informational purposes only. Mentions of specific investments should not be construed as financial advice. Conduct personalized research and consider consulting with an investment advisor before investing.
